Jørgen Bjerggaard Jensen
Clinical trials sponsored by Jørgen Bjerggaard Jensen, explained in plain language.
-
Blood test guides immunotherapy for bladder cancer: a smarter approach?
Disease control OngoingThis study tests whether starting immunotherapy early, guided by a sensitive blood test that finds tumor DNA, can better treat bladder cancer that has spread after bladder removal surgery. About 154 adults with signs of cancer in their blood (but not always visible on scans) will…
Phase: PHASE2 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Bladder cancer patients may get relief: shorter treatment time tested
Symptom relief OngoingThis study tests if reducing the time a bladder cancer treatment (BCG) stays in the bladder can lessen side effects for high-risk patients. About 314 adults from Nordic countries who experience severe side effects will be randomly assigned to a shorter or standard dwell-time. The…
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Symptom relief
Last updated May 26, 2026 07:14 UTC